Funding
PrimaDiag, a start-up developing tools to automate biological processes for diagnostics and research, has closed its second business angel-financed round, at €365,000. Angel investors in the round included Sibessor and Investessor. This follows an earlier round of €96,000 raised at the end of 2008.
The new funding will enable PrimaDiag to continue the development of applications on its proprietary robotic platform and move into production-oriented activities. PrimaDiag is based in the Biocitech life science park just outside Paris. The company claims to be the first French manufacturer to offer automation of biological processes at a budget price. According to PrimaDiag, 80 per cent of medium and small size labs are not automated.
“I am really pleased at the confidence shown in PrimaDiag by these new investors,” said Guillaume Lhermite, CEO at PrimaDiag. “These additional funds will be extremely helpful in negotiating new deals with partners in the industry.”
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.